Tyck till om SwePub Sök
här!
Sökning: onr:"9849983" >
Hope or hype
Hope or hype the obsession with medical advances and the high cost of false promises / Richard A. Deyo, Donald L. Patrick.
-
Deyo, Richard A. (författare)
-
Patrick, Donald L. (författare)
- New York : AMACOM, American Management Association, c2005.
- Engelska xvi, 335 p.
Innehållsförteckning
Ämnesord
Stäng
- Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
- Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
Ämnesord
- Utvärdering (sao)
- Medical innovations -- United States -- Evaluation. (LCSH)
- Medical technology -- United States -- Evaluation. (LCSH)
- Medical care -- Technological innovations -- United States -- Evaluation. (LCSH)
- Medical care -- United States -- Evaluation. (LCSH)
- Medical innovations -- Economic aspects -- United States. (LCSH)
- Medical technology -- United States -- Cost effectiveness. (LCSH)
- Medical care -- Technological innovations -- United States -- Cost effectiveness. (LCSH)
- Medical care, Cost of -- United States. (LCSH)
- Medicinska innovationer -- ekonomiska aspekter -- Förenta staterna (sao)
- Medcinsk teknik -- ekonomiska aspekter -- Förenta staterna (sao)
- Evaluation (LCSH)
Genre
- Electronic books. (LCSH)
Nyckelord
- V Medicin
- V Medicin
Publikations- och innehållstyp
- RA418.5.M4 (LCC)
- 610/.28 (DDC)
- V/DR (kssb/7)
- V (kssb/7)